latest development

London (UK), Rehovot (IL), October 26th, 2023 

Vidac Pharma Holdings Plc. (SYM: T9G; ISIN: GB00BM9XQ619; WKN: A3DTUQ).

Vidac Pharma Holding Plc is happy to announce Granting of a new Patent in China

One of the most important patent applications of the Company covering new chemical entities aiming at treating solid Tumors and presently under advanced pre-clinical development received Notice of Allowance in China after being allowed in Australia and USA. China is one of the most diligent and difficult Patent Office for granting Intellectual Property (IP) protection on its huge territory. Granting of this Patent might open possibilities of cooperation with the growing Chinese Pharmaceutical Industry. This achievement consolidates the already comprehensive Company intellectual property portfolio.

“Dr Max Herzberg Chairman of Vidac Pharma declared that Granting of this Patent in China constitutes an achievement further consolidating our IP international position”


The following information does not constitute a public offer to sell or a solicitation to submit an offer to buy or subscribe to shares of Vidac Pharma Holding PLC, but is for informational purposes only.

Vidac Pharma Holding PLC
Dr. Max Herzberg
20-22 Wenlock Road
London N1 7GU
United Kingdom


 +972 (0)779300647